What do you think, how many people still take their prescribed drugs after 12? My name is Urban Fritsche from Kieger.
Actually, the numbers are quite scary and vary significantly by the type of the disease. What is really scary, that even in disease conditions which are life threatening, often patients do not take their drugs.
So, for example: only 1 in 4 patients takes their asthma drug after 12 months, ony every second patients takes their diabetes medication after 12 months and just a little more than half of the patients take their HIV and MS drugs after one year.
These facts about drug compliance are another way to express the high unmet medical needs in our society. There is clear need for better therapies and medications. We need drugs with less side effects, drugs which are more effective and drugs which have long acting mechanisms in order to improve compliance of patients. Drug costs only make up for around 10% of total healthcare costs and especially chronic disease are important to control as they often lead to secondary malignancies if these diseases are not treated what increases overall costs to the society. Non-adherence costs are estimated to reach USD 290 bn as for example 10% of all hospitalizations go back to bad adherence to therapy.
Detecting cancer early on can make such a big difference. The good news is that cancer screening will get much easier in the future.
February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.